160 related articles for article (PubMed ID: 10475192)
1. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy.
Vaidya B; Imrie H; Perros P; Dickinson J; McCarthy MI; Kendall-Taylor P; Pearce SH
Lancet; 1999 Aug; 354(9180):743-4. PubMed ID: 10475192
[TBL] [Abstract][Full Text] [Related]
2. CTLA-4 and HLA gene susceptibility to thyroid-associated orbitopathy.
Buzzetti R; Nisticò L; Signore A; Cascino I
Lancet; 1999 Nov; 354(9192):1824. PubMed ID: 10577673
[No Abstract] [Full Text] [Related]
3. The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease.
Zaletel K; Krhin B; Gaberscek S; Pirnat E; Hojker S
Thyroid; 2002 May; 12(5):373-6. PubMed ID: 12097196
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans.
Park YJ; Chung HK; Park DJ; Kim WB; Kim SW; Koh JJ; Cho BY
Thyroid; 2000 Jun; 10(6):453-9. PubMed ID: 10907987
[TBL] [Abstract][Full Text] [Related]
5. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.
Donner H; Rau H; Walfish PG; Braun J; Siegmund T; Finke R; Herwig J; Usadel KH; Badenhoop K
J Clin Endocrinol Metab; 1997 Jan; 82(1):143-6. PubMed ID: 8989248
[TBL] [Abstract][Full Text] [Related]
6. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
[TBL] [Abstract][Full Text] [Related]
7. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations.
Bednarczuk T; Hiromatsu Y; Fukutani T; Jazdzewski K; Miskiewicz P; Osikowska M; Nauman J
Eur J Endocrinol; 2003 Jan; 148(1):13-8. PubMed ID: 12534352
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.
Agarwal K; Czaja AJ; Jones DE; Donaldson PT
Hepatology; 2000 Jan; 31(1):49-53. PubMed ID: 10613727
[TBL] [Abstract][Full Text] [Related]
9. The immunogenetics of thyroid-associated orbitopathy.
Weetman AP; Hunt PJ
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S149-51. PubMed ID: 10614909
[No Abstract] [Full Text] [Related]
10. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism.
Vaidya B; Oakes EJ; Imrie H; Dickinson AJ; Perros P; Kendall-Taylor P; Pearce SH
Clin Endocrinol (Oxf); 2003 Jun; 58(6):732-5. PubMed ID: 12780750
[TBL] [Abstract][Full Text] [Related]
11. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
Zhang Q; Yang YM; Lv XY
J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
[TBL] [Abstract][Full Text] [Related]
12. CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease.
Hadj Kacem H; Bellassoued M; Bougacha-Elleuch N; Abid M; Ayadi H
Clin Immunol; 2001 Dec; 101(3):361-5. PubMed ID: 11726229
[TBL] [Abstract][Full Text] [Related]
13. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33.
Heward JM; Allahabadia A; Armitage M; Hattersley A; Dodson PM; Macleod K; Carr-Smith J; Daykin J; Daly A; Sheppard MC; Holder RL; Barnett AH; Franklyn JA; Gough SC
J Clin Endocrinol Metab; 1999 Jul; 84(7):2398-401. PubMed ID: 10404810
[TBL] [Abstract][Full Text] [Related]
14. MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.
Allahabadia A; Heward JM; Nithiyananthan R; Gibson SM; Reuser TT; Dodson PM; Franklyn JA; Gough SC
Lancet; 2001 Sep; 358(9286):984-5. PubMed ID: 11583755
[TBL] [Abstract][Full Text] [Related]
15. Susceptible alleles of the CD40 and CTLA-4 genes are not associated with the relapse after antithyroid withdrawal in Graves' disease.
Kim KW; Park YJ; Kim TY; Park DJ; Park KS; Cho BY
Thyroid; 2007 Dec; 17(12):1229-34. PubMed ID: 17949264
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 gene A-G polymorphism and childhood Graves' disease.
Yung E; Cheng PS; Fok TF; Wong GW
Clin Endocrinol (Oxf); 2002 May; 56(5):649-53. PubMed ID: 12030917
[TBL] [Abstract][Full Text] [Related]
17. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
[TBL] [Abstract][Full Text] [Related]
18. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism.
Kotsa K; Watson PF; Weetman AP
Clin Endocrinol (Oxf); 1997 May; 46(5):551-4. PubMed ID: 9231050
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients.
Valenti L; De Feo T; Fracanzani AL; Fatta E; Salvagnini M; Aricò S; Rossi G; Fiorelli G; Fargion S
Alcohol Alcohol; 2004; 39(4):276-80. PubMed ID: 15208156
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus.
Pullmann R; Lukác J; Skerenová M; Rovensky J; Hybenová J; Melus V; Celec S; Pullmann R; Hyrdel R
Clin Exp Rheumatol; 1999; 17(6):725-9. PubMed ID: 10609073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
